Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | NASDAQ | Biotechnology | $9.68B | $90.21 | 1.96% | -$6.87M | 196.11x | 0.28 | United States | ||
| LQDA | LIQUIDIA CORP | NASDAQ | Biotechnology | $7.02B | $78.93 | -0.49% | $53.57M | 328.88x | 2.70 | United States | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | NASDAQ | Biotechnology | $41.76B | $312.78 | 3.68% | $924.47M | 71.74x | 3.77 | United States | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | NASDAQ | Biotechnology | $1.43B | $8.28 | 3.50% | $53.43M | 118.29x | 29.13 | United States | ||
| KRYS | KRYSTAL BIOTECH INC | NASDAQ | Biotechnology | $11.06B | $375.07 | 0.94% | $213.96M | 48.40x | 0.09 | United States | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | NASDAQ | Biotechnology | $4.96B | $64.53 | 2.62% | $111.49M | 65.85x | 0.36 | Bermuda | ||
| HALO | HALOZYME THERAPEUTICS INC | NASDAQ | Biotechnology | $9.42B | $79.45 | 3.17% | $623.82M | 26.84x | 11.17 | United States | ||
| VCEL | VERICEL CORP | NASDAQ | Biotechnology | $2.40B | $46.98 | 4.05% | $40.42M | 109.26x | 0.36 | United States | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | $11.40B | $58.99 | 2.02% | $482.49M | 42.14x | 0.38 | United States | ||
| RPRX | ROYALTY PHARMA PLC | NASDAQ | Biotechnology | $33.27B | $57.77 | 3.57% | $1.16B | 30.25x | 0.99 | United States | ||
| ADMA | ADMA BIOLOGICS INC | NASDAQ | Biotechnology | $2.07B | $8.95 | 3.95% | $221.54M | 12.97x | 0.70 | United States | ||
| ZVRA | ZEVRA THERAPEUTICS INC | NASDAQ | Biotechnology | $826.43M | $13.98 | 1.23% | $144.61M | 6.82x | 0.35 | United States | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | $15.28B | $243.47 | 2.51% | $675.03M | 518.02x | 1.62 | Ireland | ||
| ASND | ASCENDIS PHARMA A | NASDAQ | Biotechnology | $17.05B | $274.50 | 2.51% | $93.26M | 29.09x | 3.11 | Denmark | ||
| TGTX | TG THERAPEUTICS INC | NASDAQ | Biotechnology | $8.16B | $53.31 | -0.39% | $150.00M | 16.56x | 1.62 | United States | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | NASDAQ | Biotechnology | $2.16B | $37.26 | 3.50% | $236.96M | 14.73x | 0.40 | United States | ||
| LGND | LIGAND PHARMACEUTICALS INC | NASDAQ | Biotechnology | $6.40B | $319.55 | 2.42% | $225.55M | 40.45x | 0.54 | United States | ||
| TECH | BIO-TECHNE CORP | NASDAQ | Biotechnology | $11.09B | $70.83 | -0.24% | $255.98M | 99.76x | 0.22 | United States | ||
| SPRO | SPERO THERAPEUTICS INC | NASDAQ | Biotechnology | $127.38M | $2.20 | -0.90% | $15.50M | 8.15x | 0.12 | United States | ||
| EXEL | EXELIXIS INC | NASDAQ | Biotechnology | $14.04B | $55.85 | 3.50% | $1.06B | 17.90x | 0.34 | United States | ||
| VRTX | VERTEX PHARMACEUTICALS INC | NASDAQ | Biotechnology | $134.02B | $528.04 | 6.03% | $5.39B | 31.04x | 0.37 | United States | ||
| NAGE | NIAGEN BIOSCIENCE INC | NASDAQ | Biotechnology | $273.18M | $3.43 | 3.00% | $21.24M | 14.29x | 0.39 | United States | ||
| UTHR | UNITED THERAPEUTICS CORP | NASDAQ | Biotechnology | $23.60B | $555.91 | 1.60% | $1.71B | 18.99x | 0.14 | United States | ||
| CPRX | CATALYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | $3.85B | $31.45 | 0.03% | $334.94M | 17.38x | 0.13 | United States | ||
| REGN | REGENERON PHARMACEUTICALS INC | NASDAQ | Biotechnology | $68.59B | $654.27 | 4.73% | $5.74B | 15.37x | 0.30 | United States | ||
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | $4.55B | $57.08 | -4.63% | $115.05M | 51.42x | 0.07 | United States | ||
| INCY | INCYTE CORP | NASDAQ | Biotechnology | $23.35B | $116.86 | 2.68% | $1.87B | 16.03x | 0.31 | United States | ||
| SRPT | SAREPTA THERAPEUTICS INC | NASDAQ | Biotechnology | $2.04B | $19.28 | 5.93% | $82.73M | 32.13x | 1.11 | United States | ||
| MDXG | MIMEDX GROUP INC | NASDAQ | Biotechnology | $588.34M | $3.95 | 1.28% | $54.47M | 18.81x | 0.27 | United States |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.